Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial – ET HealthWorld

NEW DELHI: Pharmaceutical major Mylan NV on Monday said it has received approval from Indian drugs regulator DCGI to manufacture and market its remdesivir for restricted emergency use in the country for the treatment of COVID-19. The drug will be priced at Rs 4,800 per 100 mg vial and would be available to the patients […]

Kerala: Sree Chitra’s RNA extraction kits in market soon - ET HealthWorld

Kerala: Sree Chitra’s RNA extraction kits in market soon – ET HealthWorld

KOCHI: Giving impetus to government’s efforts to increase number of tests to diagnose Covid-19, RNA extraction kits developed by Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) are all set to hit the market soon. Drugs Controller General of India (DCGI) approved commercial production and National Institute of Virology, Alappuzha, completed final validation […]